Gauging the efficacy of neoadjuvant endocrine therapy in breast cancer patients with known axillary disease.

Jacob B HammondTaylor H ParnallDerek W ScottHeidi E KosiorekBarbara A PockajBrenda J ErnstDonald W NorthfeltAnn E McCulloughIdris Tolgay OcalPatricia A Cronin

Published in: Journal of surgical oncology (2020)

While NET is reported to downstage primary tumors, downstaging of the axilla was unsuccessful in the majority of patients.

Keyphrases

lymph node
end stage renal disease
ejection fraction
newly diagnosed
sentinel lymph node
chronic kidney disease
prognostic factors
peritoneal dialysis
neoadjuvant chemotherapy
stem cells
young adults
squamous cell carcinoma
locally advanced
patient reported outcomes
mesenchymal stem cells
ultrasound guided